Submitted by Andy Guess on October 17, 2008 - 4:00am
Last summer, the group representing major research universities endorsed legislation that sought to balance the interests of drug makers and the scientists whose work can translate into new advances in medicine. At least one group, however, is sounding the alarm that the bill would make it more difficult to bring cheap, generic drugs to the market -- at the expense of both American consumers and people in developing countries.
President Obama on Monday made good on his campaign promise to lift the restrictions imposed by President George W. Bush on federal support for stem cell research. At the same time, the president issued a strong statement on the importance of protecting science from political interference -- and pledged that his administration's policies would be based on sound scientific advice and would not impose ideological tests on researchers.